ClinConnect ClinConnect Logo
Search / Trial NCT06855459

The Impact of Biophoton Therapy on Self-Grown Stem Cells

Launched by FIRST INSTITUTE OF ALL MEDICINES · Feb 26, 2025

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Biophoton Therapy, Tesla Bio Healing, Stem Cells; Increase Stem Cells

ClinConnect Summary

This clinical trial is looking at a new treatment called biophoton therapy to see if it can help increase the number of stem cells your body naturally produces. Stem cells are important because they can develop into different types of cells in the body and are involved in healing and repair. The trial will involve about 46 volunteers who are interested in boosting their stem cell levels. Participants will be randomly assigned to either receive the biophoton therapy or a placebo (a treatment that looks the same but has no active ingredients) without knowing which one they are getting for the first two weeks.

To be eligible for this trial, you should be between 18 and 70 years old, in good health without major diseases, and able to understand and agree to participate. You should also not have used biophoton devices frequently in the past. If you are interested, expect to sign an informed consent form and follow some study requirements. This trial is currently recruiting participants, so if you meet the criteria and want to be involved, you could help researchers learn more about this potential treatment!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Willing and able to give informed consent for participation in the trial.
  • Is able and willing to comply with all trial requirements.
  • Male or female ages 18-70 years old without major diseases.
  • Participants must not be heavy users of Tesla BioHealing devices; enrollment will be determined by the clinical team based on an evaluation of the participant's prior device usage.
  • Must be fluent in English.
  • Exclusion Criteria:
  • Untreated psychiatric disturbances that would affect trial participation as judged by the research medical professional.
  • Is participating in another investigational drug or device trial
  • Had been treated with Stem Cell therapy within a 6-month period.

About First Institute Of All Medicines

The First Institute of All Medicines is a pioneering clinical trial sponsor dedicated to advancing the field of pharmaceutical research and development. Committed to innovation and excellence, the institute focuses on conducting rigorous clinical trials that evaluate new therapeutic interventions across various medical disciplines. By fostering collaboration between researchers, healthcare professionals, and regulatory bodies, the institute aims to accelerate the discovery of safe and effective treatments, ultimately enhancing patient outcomes and improving public health. With a strong emphasis on ethical practices and scientific integrity, the First Institute of All Medicines is at the forefront of transforming healthcare through cutting-edge research.

Locations

Tampa, Florida, United States

Butler, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

James Z Liu, MD, PhD

Study Chair

First Institute of All Medicines

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported